Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 4, 1998, Pages 323-328

  Sheng, Jin G ^a,e   Mrak, Robert E ^b,d   Griffin, W Sue T ^a,b,c,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Education and Clinical Center   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; DNA damage; Neurofibrillary tangles; Tau; TUNEL

Indexed keywords

DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0031919135     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199804000-00003     Document Type: Article

References (22)

1. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
2. Arriagada PV, Growdin JH, Hedley-White ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity in Alzheimer's disease. Neurology 1992;42:631-39
3. Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Zentralbl gsante Neurol Psychiatrie 1907;18:177-79
4. Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Z Psychiatrie 1907;64:146-48
5. Griffin WST, Ling C, White CL, III, Morrison-Bogorad MR. Polyadenylated messenger RNA in paired helical filament immunoreactive cells in Alzheimer senile dementia. Alzheimer Disease Assoc Dis Int J 1990;4:69-78
6. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: Correlations with senile plaques and disease progression. J Neuropath Exp Neurol 1996;55:1134-43
7. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of program cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
8. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 1994;5:2529-33
9. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995;89:35-41
10. Smale G, Nichols NY, Brady DR, Finch CE, Horton WE. Evidence for apoptotic cells death in Alzheimer's disease. Exp Neurol 1995;133:225-30
11. Anderson A, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease colocalization with c-jun immunoreactivity, relationship to brain area and effect of postmortem delay. J Neurosci 1996;16:1710-19
12. Mullaart E, Boerrigter ME, Ravid R, Swaab DF, Vijg J. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging 1990;11:169-73
13. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:497-86
14. Sheng JG, Mrak RE, Griffin WST. S100β protein expresses in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994;39:398-404
15. + astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 1997;56:285-90
16. Tominaga T, Kure S, Narisawa K, Yoshimoto T. Endonuclease activation following focal ischemic injury in the rat brain. Brain Res 1993;608:21-26
17. Lucassen PJ, Chung WCJ, Kamphorst W, Swaab DF. DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 1997;56:887-900
18. Petito CK, Roberts B. Effect of postmortem interval on in situ end-labelling of DNA oligonucleosomes. J Neuropathol Exp Neurol 1995;54:761-65
19. Brenneman DE, Page SW, Schultzberg M, et al. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms. J Pharmacol Exp Ther 1993;266:1029-35
20. Griffin WST, Sheng JG, Mrak RE. Inflammatory pathways, implications in Alzheimer's disease. Molecular mechanism of dementia. Wasco W, Tanzi RE, eds. Totowa, NJ: Humana Press Inc; 1996:169-75
21. Barger SW, Van Eldik LJ. S100β stimulates calcium fluxes in glial and neuronal cells. J Biol Chem 1992;267:9689-94
22. Grundke-Iqbal I, Iqbal K, Tung WC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of microtubule-associated protein J (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913-17